Iovance Biotherapeutics, Inc. IOVA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s interest income?
- Iovance Biotherapeutics, Inc. (IOVA) reported interest income of $1.33M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s interest income changed year-over-year?
- Iovance Biotherapeutics, Inc.'s interest income decreased by 58.6% year-over-year, from $3.22M to $1.33M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s interest income has grown at a 118.6% compound annual growth rate (CAGR), from $451K to $10.31M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.